Contents & References of The effect of 8 weeks of aerobic training and omega-3 supplement consumption on inflammatory indices of type 2 diabetic patients
List:
A) Table of Contents
Chapter One: General Research 1
1-1- Introduction.. 1
1-2- Statement of the problem. 2
1-3- The importance and necessity of research. 5
1-4- research objectives. 6
Special goals.. 6
Special goals. 6
1-5- Hypotheses.. 7
1-6- Scope of research. 7
1-7- research limitations. 7
1-8- Definition of words. 8
Chapter Two: Theoretical foundations and research background 9
1-2- Introduction.. 10
2-2- Theoretical foundations of research. 10
2-2-1- obesity.. 10
2-2-2- metabolic syndrome. 11
2-2-3-insulin resistance. 12
2-2-4- diabetes mellitus (second type). 13
2-2-5- Pathophysiology of type 2 diabetes. 14
2-2-6- adipose tissue. 15
2-2-7- Fat tissue metabolism. 15
2-2-8- proteins derived from fat. 16
2-2-9- An overview of the safety device. 17
2-2-10- Overview of the safety device. 17
2-2-10- Intrinsic safety and acquired safety. 17
2-2-11- cells of the immune system. 19
2-2-12-white blood cells. 19
2-2-13- Inflammation. 21
2-2-14- Soluble factors in immune responses. 21
2-2-15- Cytokines. 22
2-2-16-interleukin ?1 (?1-IL). 24
2-2-17- tumor necrosis factor (TNF). 25
2-2-18- fat (lipids). 27
2-2-19- Fatty acids. 27
2-2-20- Omega-3 fatty acids. 28
2-2-21- EPA, DHA. 29
2-2-22- Consumption of fatty acids in human diet. 31
2-2-23- How fatty acids affect the immune system. 32
2-2-24- prostoglandin 2E and leukotriene 4L. 34
2-2-25-4L.. 34
2-2-26-2PGE. 34
2-2-27- The effect of omega-3 on the immune system............................ 36
2-2-28- The mechanism of the effect of PUFAs on inflammatory factors. 36
2-2-29- The short-term effect of omega-3 consumption on the immune system....................... 40
2-2-30- Physical activity and 3n- PUFAs supplement. 41
2-2-31- Increasing exercises. 44
2-3- Research background. 45
Chapter Three: Research Methodology 55
3-1- Introduction.. 56
3-2- Research method. 56
3-3- Society and statistical sample. 56
3-4- Research variables. 57
3-5- Consumables, tools and data collection methods. 58
3-6- Measuring tools. 59
3-6-1- Measuring the maximum heart rate (HR max). 59
3-6-2- Blood sampling. 61
3-6-3- Measurement of TNF-?, ? 1-IL and insulin. 61
3-6-4- Measurement of height and weight. 62
3-7- How to take supplements. 62
3-8- Laboratory methods. 62
3-8-1- Blood sample collection. 62
3-8-2- Isolation of peripheral blood mononuclear cells (PBMC). 63
3-8-3-cultivation of PBMC cells and their stimulation to PHA. 63
3-9- Statistical methods. 63
Chapter Four: Statistical Analysis 65
4-1- Introduction.. 66
4-2- Description of data. 66
4-3- Test of hypotheses. 67
The first hypothesis.. 66
The second hypothesis.. 68
The third hypothesis.. 70
The fifth chapter: discussion and conclusion 73
Discussion and conclusion. 74
5-1- Introduction..74
5-2- Summary.. 74
Conclusion.. 80
5-3-Proposals from the research. 81
5-4- Suggestions for future research: Sources. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: WHO/IDF Consultation; 2006
2-World Health Organization and International Diabetes Federation. Diabetes Action Now: An Initiative of World Health Organization and International Diabetes Federation, 2004
3- Rawal LB, Tapp RJ, Williams ED, Chan C, Yasin S, Oldenburg B. Prevention of Type 2 Diabetes and Its Complications in Developing Countries: A Review. Int J Behav Med. 2011;4:18-28
4-Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, et al. National standards for diabetes self-management education. Diabetes Care. 2008 January; 31 Suppl 1: S97-104
5-Thomas GN, Jiang CQ, Taheri2008 January; 31 Suppl 1: S97-104
5-Thomas GN, Jiang CQ, Taheri S, Xiao ZH, Tomlinson B, Cheung BM, et al. A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes. Curr Diabetes Rev. 2010;6:378-8
6-Brunner, E.J. Kivimaki, M. Witte, D.R. Lawlor, D.A. Daveysmith, G. Gooper, J.A. Miller, M. Lowe, G.D. Rummley, A. Casas.J.P. Shah T. Humphries, S.E. Hingorani, A.D. Maarmot, M.G.Timpson, N.J. and Kumari, M. 2008
7-Gomez, J.M. Vila, R. Catalina, P. Soler, J. Badimon, L. and Sahum, M. 2008. The markers of inflammation and endothelial dysfunction in correlation with glycated hemoglobin are present in type 2 diabetes mellitus patients but not their relatives. Glycoconj J, 25(6), pp. 573-579
8-Yaturu, S. Rains, J. and Jain, S.K. 2008. Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes. Cytokine, 44(1), pp. 168-171.
9-simopoulos, A.P. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr, 21(6), pp. 495-505.
10-Martin, R.E. 1998. Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells. J Neurosci Res,54(6),pp.805-813
11-Kang, J.X. man, S.F. Brown, N.F. Labrecque, P, A. Garg, M.L. and Clandinin, M.T. 1992. Essential fatty acid metabolism in cultured human airway epithelial cells. Biochem Biophys Acta, 1128(2-3), pp.267-274.
12-Horia, E. and Watkins, B.A. 2007. Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and in MDA-MB-231 breast cancer cells. Carcinogenesis, 28(4), pp. 809-815
13-Saedisomeolia, A. Wood. L.G. Garg, M.L. Gibson, P.G. and Wark, P.A. 2009. Anti-inflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells. Br J nutr,101(4),pp.533-540.
14-Marik, P.E. and Varon, J. 2009. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol,32(7),pp,365-372.
15-Freund-Levi,Y. Hjorth, E, Lindberg, C. Cederholm, T. Faxen-Irvin. and Eriksdotter Jonhagen, M. 2009. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegaAD study. Dement Gogn Disord, 27(5). pp. 481-490.
16-Suresh.Y. and Das. U.N. 2003. Longchain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of omega-3 fatty acids. Nutrition, 19(3), pp. 213-228.
17-Tsitouras, P.D. Gucciardo, F. Salbe, A.D. Heward, C. Harman, S.M. 2008. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6. But does not affect other endocrine axes in healthy older adults. Horm Metab Res,40(3), pp.199-205.
18-Gleeson, M.(2000). Mucosal immune responses and risk of respiratory illness in elite athletes. Exerc Immunol Rev. 6:5-42, 2000.
19-Pan DA, S.Lillioja, A.D Kriketos. skeletal muscle triglyceride levels are inversely related to insulin action.Diabetes.46:983-988.1997
20-Kesaniemi YA, E. Danforth, M.D. Jensen. P.G.Kopelmmn, P.Lefebvre, B.A.Reeder. Dose-response issues concerning physical activity and healh: an evidence-based symposium. Med Sci Sport Excerc. 33: S351-S358. 2001
(21 Larijani, Bagher; Prevalence of type 2 diabetes in Iran in 1380; Iranian Journal of Diabetes and Lipid; Volume 4 (Number 3); 83-75. Spring 1384
22-Thompson PD,S.F Crouse,B.Goodpaster,D.Kelly,N.Moyan,L.Pescatello.The acute versus chronic response to excess.Med Sci Sport Excerc.33:S-438-445.2001
23-Calder PC (2005) Biochemical Society Transactions 33, 423-427.
24-Glaser R, Robles T, Malarkey WB, Kiecolt-Glaser JK. (2003). Mild depressive symptoms are associated with amplified and prolonged inflammatory responses in older adults. Arch Gen Psychiatry 2003;60:1009-14. Fatty acids as modulators of the immune response.